United States · FDA National Drug Code directory
Tudriqev
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83616-106_5a6cd8e9-9d15-d428-e063-6294a90a4dfb
- Product NDC
- 83616-106
- Form
- INJECTION, SUSPENSION
- Composition / generic term
- vusolimogene oderparepvec-wtpg
- Labeler
- Replimune, Inc.
- Marketing category
- BLA
- Marketing start / end (source format)
- 20260904
- Source listing expiry
- 20271231
Source-listed ingredients
- VUSOLIMOGENE ODERPAREPVEC — 1000000 [PFU]/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 VIAL, SINGLE-DOSE in 1 CARTON (83616-106-11) / 1 mL in 1 VIAL, SINGLE-DOSE (83616-106-01) · 83616-106-11
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →